SFBC International Selects eResearchTechnology to Provide Integrated Suite of Software for Managing Late-Stage Drug Development
29 June 2004 - 12:08AM
PR Newswire (US)
SFBC International Selects eResearchTechnology to Provide
Integrated Suite of Software for Managing Late-Stage Drug
Development Services PHILADELPHIA and MIAMI, June 28
/PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT),
(NASDAQ:ERES), a leading e-research technology and services
provider, announced today that it has entered into an agreement to
provide SFBC International, Inc. (NASDAQ:SFCC), a provider of
specialized drug development services to global and specialty
pharmaceutical, biotechnology and generic drug companies, with an
integrated technology and services solution that includes an
end-to-end clinical research platform, electronic data capture and
a web portal for clients' access to real-time data. Financial terms
of the agreement were not disclosed. The integrated suite of
software and technology that eRT will provide to SFBC will include
its eResearch Network, Enterprise EDC platform and eResearch
Community web portal. eRT's eResearch Network integrated suite of
applications for clinical data management, trial management and
monitoring, and adverse event management and reporting will be
deployed to support development of harmonized processes across all
key aspects of clinical development for SFBC, a rapidly expanding
provider of comprehensive services for all phases of clinical
development. eRT's Enterprise EDC platform will be implemented to
support SFBC's ability to provide sponsors with an electronic data
capture solution that can scale from a single trial to an entire
development program. In addition, SFBC will deploy eRT's eResearch
Community web portal for overall command and control, real-time
analysis and decision support, and collaboration and communications
across its clinical research network. SFBC anticipates that the
software implementation will commence in the third quarter of 2004
and be completed in the first quarter of 2005. In April 2003, the
companies announced a non-exclusive alliance for providing
integrated solutions for thorough Phase I ECG studies, which
monitor cardiac safety and a drug's impact on the QTc interval.
Under this alliance, SFBC conducts thorough QTc interval trials at
its Phase I/II facilities in the U.S. and Canada, while eRT
performs digital collection, measurement, interpretation, review
and distribution of cardiac safety data through its EXPeRT
workflow-enabled data handling technology. "We are delighted to
have been selected by SFBC to provide a clinical data technology
infrastructure that will support harmonization of activities across
all phases of clinical development for an expanding network of
locations," said Joe Esposito, eRT's president and chief executive
officer. "This agreement to provide eRT's Enterprise EDC,
end-to-end eResearch Network, and eResearch Community portal, in
combination with the existing alliance to provide turnkey solutions
in the mission critical Thorough Phase I ECG Study arena,
illustrates eRT's unique capabilities to provide the technology and
services required for new drug development industry leaders to
achieve best practices." Dr. Gregory B. Holmes, executive vice
president of clinical operations for SFBC International, commented,
"Based on the rapid growth of our business and our business
outlook, we believe it is the right time to implement a
comprehensive suite of software and services for our late-stage
development business that will enable us to enhance the level of
service we currently provide to our clients through the integration
of data management, electronic data capture and real-time data
access. We selected eRT for our new software implementation because
of its user-friendly and cost-effective integrated clinical data
technology solution." About SFBC International, Inc. SFBC
International, Inc. is a contract research organization, providing
a range of specialized drug development services to pharmaceutical,
biotechnology and generic drug companies. The company is a provider
of early clinical development services, specializing primarily in
the areas of Phase I and Phase II clinical trials and bioanalytical
laboratory services. SFBC also provides a range of complementary
services to its clients, including early clinical pharmacology
research, biostatistics and data management, and regulatory and
drug submission as well as Phase III and Phase IV clinical trial
management services in select therapeutic areas. Additional
information is available at the Company's website,
http://www.sfbci.com/ or contact Evan Smith or Erica Pettit, KCSA
Worldwide, at 212-682-6300. About eResearchTechnology, Inc. Based
in Philadelphia, PA, eResearchTechnology, Inc.
(http://www.ert.com/) is a provider of technology and services to
the pharmaceutical, biotechnology and medical device industries on
a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology
and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technology and services
to streamline the clinical trials process by enabling its customers
to automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements in this
release including the implementation and completion of installation
of the eRT software constitute forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements involve a number of risks and uncertainties
such as technological development and available personnel. As a
result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors
that could affect the realization of the forward-looking statements
can be found in each company's filings with the Securities and
Exchange Commission including their Forms 10-K and 10-Q.
DATASOURCE: eResearchTechnology, Inc.; SFBC International CONTACT:
Joan Sterlacci of eResearchTechnology, +1-908-203-6473; or Matt
Hayden of Hayden Communications, +1-858-456-4533, for
eResearchTechnology; or Ana Lopez of SFBC International,
+1-305-895-0304; or Evan Smith, CFA, +1-212-896-1251, or Erica
Pettit, +1-212-896-1248, both of KCSA Worldwide Web site:
http://www.ert.com/ http://www.sfbci.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024